First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Shares Up 0.5% – Still a Buy?

by · The Cerbat Gem

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH – Get Free Report) shares traded up 0.5% during trading on Friday . The company traded as high as $33.17 and last traded at $33.12. 2,267 shares traded hands during trading, a decline of 63% from the average session volume of 6,206 shares. The stock had previously closed at $32.94.

First Trust Nasdaq Pharmaceuticals ETF Trading Up 0.5%

The stock has a market capitalization of $21.53 million, a P/E ratio of 14.51 and a beta of 0.54. The company has a 50-day moving average price of $32.00 and a two-hundred day moving average price of $29.03.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 31st. Shareholders of record on Friday, December 12th were issued a $0.1294 dividend. This represents a $0.52 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date was Friday, December 12th.

Institutional Trading of First Trust Nasdaq Pharmaceuticals ETF

Several large investors have recently modified their holdings of FTXH. Raymond James Financial Inc. acquired a new position in shares of First Trust Nasdaq Pharmaceuticals ETF during the 2nd quarter valued at $57,000. Steph & Co. bought a new stake in First Trust Nasdaq Pharmaceuticals ETF in the third quarter valued at $142,000. Stratos Wealth Partners LTD. acquired a new position in shares of First Trust Nasdaq Pharmaceuticals ETF during the third quarter valued at about $230,000. Bank of Montreal Can boosted its position in shares of First Trust Nasdaq Pharmaceuticals ETF by 68.2% during the 2nd quarter. Bank of Montreal Can now owns 8,221 shares of the company’s stock worth $211,000 after purchasing an additional 3,333 shares in the last quarter. Finally, Vivaldi Capital Management LP boosted its position in shares of First Trust Nasdaq Pharmaceuticals ETF by 4.1% during the 3rd quarter. Vivaldi Capital Management LP now owns 9,790 shares of the company’s stock worth $279,000 after purchasing an additional 384 shares in the last quarter.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

(Get Free Report)

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.

Further Reading